Abstract
Roxadustat is a recently approved hypoxia-inducible factor prolyl hydroxylase inhibitor that has demonstrated favorable safety and efficacy in the tre......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
